0000899243-19-014054.txt : 20190517 0000899243-19-014054.hdr.sgml : 20190517 20190517195842 ACCESSION NUMBER: 0000899243-19-014054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stueland Katherine CENTRAL INDEX KEY: 0001689575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 19837350 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-15 0 0001501134 Invitae Corp NVTA 0001689575 Stueland Katherine C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Commercial Officer Common Stock 2019-05-15 4 S 0 1000 18.36 D 184370 D These sales of common stock were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 14, 2018. Includes an aggregate of 157,683 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. /s/ Katherine Stueland 2019-05-17